The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center

被引:3
|
作者
Zouridis, Andreas [1 ]
Zarrindej, Kianoush [2 ]
Rencher, Joshua [3 ]
Pappa, Christina [1 ]
Kashif, Ammara [1 ]
Smyth, Sarah Louise [1 ]
Sadeghi, Negin [1 ]
Sattar, Alisha [1 ]
Damato, Stephen [1 ]
Ferrari, Federico [4 ]
Lagana, Antonio Simone [5 ]
Abdalla, Mostafa [6 ]
Kehoe, Sean [1 ]
Addley, Susan [7 ]
Majd, Hooman Soleymani [1 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford OX3 7LE, England
[2] Buckinghamshire NHS Fdn Trust, Wycombe HP11 2TT, Bucks, England
[3] Royal Berkshire NHS Fdn Trust, Reading RG1 5AN, England
[4] Univ Brescia, Dept Clin & Expt Sci, I-25136 Brescia, Italy
[5] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties PROMISE, Unit Gynecol Oncol,ARNAS Civ Di Cristina Benfratel, I-90127 Palermo, Italy
[6] Guys & St Thomas NHS Fdn Trust, Gynaecol, London SE1 9RT, England
[7] Univ Hosp Derby & Burton NHS Fdn Trust, Derby DE22 3NE, England
关键词
endometrioid endometrial cancer; grade; 3; high grade; prognosis; recurrence; CLEAR-CELL CARCINOMAS; INITIATED FOLLOW-UP; GYNECOLOGICAL MALIGNANCY; SURVIVAL; RECOMMENDATIONS; ADENOCARCINOMA; GUIDELINES; FEATURES; THERAPY; IMPACT;
D O I
10.3390/jcm12093141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High grade endometrioid endometrial cancer (HGEEC) is a heterogeneous group of tumors with unclear prognostic features. The aim of the present study is to evaluate the independent risk factors for recurrence and mortality and to describe the recurrence patterns of HGEEC. Ninety-six consecutive cases of HGEEC treated with primary surgery in a single Tertiary Center were retrospectively reviewed. Clinicopathological and treatment details were recorded, and all patients were closely followed up. Disease-free, overall and cancer-specific survival rates were 83.8%, 77.8% and 83.6%, respectively. Cervical stromal involvement was independently related to recurrence (HR = 25.67; 95%CI 2.95-223.30; p = 0.003) and cancer-related death (HR = 15.39; 95%CI 1.29-183.43; p = 0.031) after adjusting for other pathological and treatment variables. Recurrence rate was 16%, with 60% of these cases having lung metastases and only one case with single vaginal vault recurrence. 81.81% of the recurrences presented with symptoms and not a single recurrence was diagnosed in routine follow-up clinical examination. In conclusion, the recurrence pattern may suggest that patient-initiated follow-up (PIFU) could be considered a potential alternative to clinical-based follow-up for HGEEC survivors, especially for patients without cervical involvement and after two years from treatment. Additional caution is needed in patients with cervical stromal involvement.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
    Han, Kyung Hee
    Kim, Hee Seung
    Lee, Maria
    Chung, Hyun Hoon
    Song, Yong Sang
    MEDICINE, 2017, 96 (21)
  • [12] Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
    Gonzalez-Bosquet, Jesus
    Gabrilovich, Sofia
    McDonald, Megan E.
    Smith, Brian J.
    Leslie, Kimberly K.
    Bender, David D.
    Goodheart, Michael J.
    Devor, Eric
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [13] Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival
    Lee, So Jung
    Kang, Hye Jin
    Kwak, Yoo-Kang
    Kim, Myungsoo
    Kim, Jisang
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (09) : 828 - 837
  • [14] Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival
    So Jung Lee
    Hye Jin Kang
    Yoo-Kang Kwak
    Myungsoo Kim
    Jisang Kim
    Strahlentherapie und Onkologie, 2023, 199 : 828 - 837
  • [15] Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
    Dai, Yibo
    Dong, Yangyang
    Cheng, Yuan
    Hou, Hongyi
    Wang, Jingyuan
    Wang, Zhiqi
    Wang, Jianliu
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (03)
  • [16] Diabetes mellitus complications associated with recurrence of stage I endometrioid endometrial cancer: A single-center retrospective study
    Nief, Corrine A.
    Long, Sara E.
    McCleary, Tamra-Lee
    Kidd, Elizabeth
    Litkouhi, Babak
    Howitt, Brooke
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 298 - 306
  • [17] Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus
    Sahin, Hanifi
    Meydanli, Mehmet Mutlu
    Sari, Mustafa Erkan
    Kocaman, Eda
    Cuylan, Zeliha Firat
    Yalcin, Ibrahim
    Coban, Gonca
    Ozen, Ozlem
    Sirvan, Levent
    Gungor, Tayfun
    Ayhan, Ali
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (01): : 82 - 89
  • [18] High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)
    Mihalj, S. Srdelic
    Capkun, V
    Kumnic-Prusac, I
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (01) : 16 - 22
  • [19] Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer
    Kilic, Fatih
    Unsal, Mehmet
    Cakir, Caner
    Yuksel, Dilek
    Kilic, Cigdem
    Dur, Riza
    Comert, Gunsu Kimyon
    Turan, Taner
    Turkmen, Osman
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2021, 60 (06): : 1023 - 1030
  • [20] Treatment of Early Stage High-Risk Endometrioid-Type Endometrial Cancer and Patterns of Disease Relapse: A Retrospective Analysis
    Song, Jiheon
    Le, Tien
    Hopkins, Laura
    Fung-Kee-Fung, Michael
    Jooya, Alborz
    Lupe, Krystine
    Gaudet, Marc
    Samant, Rajiv
    ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (05) : 910 - 919